Investors
News & Events
Contact Us
Home
Who We Are
Company Overview
Management Team
Board of Directors
Partners
Pipeline
Clinical Programs
IRAK1/4
RIPK1
Partnered Programs
Clinical Trials
Investigator Sponsored Research
Expanded Access Policy
Products
Join Our Team
Life at Rigel
Our Values
Benefits
Current Openings
Investors
News & Events
Contact Us
Press Releases
Investors
Investors
Overview
News & Events
Press Releases
Events & Presentations
Email Alerts
Financial Info
Financial Results
Income Statement
Balance Sheet
Cash Flow
FAQ
Stock Data
Quote
Charts
Historical Data
SEC Filings
All SEC Filings
Annual Reports
Quarterly Reports
Section 16 Filings
Analyst Coverage
Governance
Management Team
Board of Directors
Board Committees
Governance Documents
ESG
News & Events
Press Releases
Events & Presentations
Email Alerts
Year
All Years
2024
2023
2022
2021
2020
2019
2018
2017
2016
2015
2014
2013
2012
2011
2010
2009
2008
2007
Category
All Releases
Financial Releases
Search terms
Search News
Dec 05, 2013 7:30am EST
Rigel to Present at Oppenheimer Healthcare Conference
Nov 05, 2013 7:30am EST
Rigel Announces Third Quarter 2013 Financial Results
Oct 24, 2013 7:30am EDT
Rigel Provides Pipeline Update
Sep 06, 2013 7:30am EDT
Rigel to Present at Stifel Healthcare Conference
Sep 05, 2013 7:30am EDT
Rigel To Focus On ITP, DLE And Dry Eye
Aug 26, 2013 7:30am EDT
Rigel's R343 Did Not Meet Primary Endpoint in Asthma Study
Aug 06, 2013 7:30am EDT
Rigel Announces Second Quarter 2013 Financial Results
Jun 04, 2013 2:00am EDT
Rigel Will Resume Responsibility for Fostamatinib Program
May 22, 2013 7:30am EDT
Rigel's R348 to Initiate Phase 2 Clinical Trial in Dry Eye
May 07, 2013 7:30am EDT
Rigel Announces First Quarter 2013 Financial Results
Previous
1…
22
23
24
25
26
27
28
29
30
31
…40
Next
Email Alerts
RSS News Feed
